Director/PDMR Shareholding
17 Mayo 2010 - 1:01AM
UK Regulatory
TIDMCRYO
RNS Number : 0137M
Cryo-Save Group NV
17 May 2010
17 May 2010
Cryo-Save Group N.V.
Director/PDMR Shareholding
Cryo-Save Group N.V.(AIM/Euronext: CRYO, 'Cryo-Save', or 'the Group'), Europe's
leading stem cell bank, has been informed today that Mr Johan Goossens,
Chairman, purchased 25,000 ordinary shares of Euro 0.10 ('Ordinary Shares') at
EUR5.78 on 14 May 2010.
Following this purchase, Johan Goossens is beneficially interested in 1,655,000
ordinary shares, representing approximately 17.92% of the Company's issued share
capital.
+------------------------------------------+--------------------+
| Enquiries: | |
+------------------------------------------+--------------------+
| | |
+------------------------------------------+--------------------+
| Cryo-Save Group | + 31 (0)575 |
| | 548998 |
+------------------------------------------+--------------------+
| Arnoud van Tulder, Chief Executive | |
| Officer | |
+------------------------------------------+--------------------+
| Marc Waeterschoot, Executive Director | |
+------------------------------------------+--------------------+
| | |
+------------------------------------------+--------------------+
| Daniel Stewart & Company plc | + 44 (0) 20 7776 |
| | 6550 |
+------------------------------------------+--------------------+
| Simon Leathers/Emma Earl | |
+------------------------------------------+--------------------+
| | |
+------------------------------------------+--------------------+
| College Hill (UK) | + 44 (0) 20 7457 |
| | 2020 |
+------------------------------------------+--------------------+
| Adrian Duffield/Rozi Morris | |
+------------------------------------------+--------------------+
| | |
+------------------------------------------+--------------------+
| SPJ Financiële Communicatie Amstelveen | +31 (0)20 647 8181 |
| (NL) | |
+------------------------------------------+--------------------+
| Kees Jongsma/Léon Melens | |
+------------------------------------------+--------------------+
About Cryo-Save
With more than 130,000 samples saved, Cryo-Save is the leading stem cell bank in
Europe and one of the fastest growing in the world. Driven by its international
business strategy, Cryo-Save is now represented in 38 countries on three
continents and has state-of-the-art processing facilities in Belgium, Germany,
Dubai, India and France (under construction).
This information is provided by RNS
The company news service from the London Stock Exchange
END
RDSLIFSEELIDLII
Cryo-Save (LSE:CRYO)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
Cryo-Save (LSE:CRYO)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024
Real-Time news about Cryo-Save (London Stock Exchange): 0 recent articles
Más de Cryo-Save Artículos de Noticias